Inhibitory Effect of Purpurogallin on Osteoclast Differentiation in Vitro through the Downregulation of c-Fos and NFATc1

Conversion to purpurogallin, a key step in the mechanism of the potent xanthine oxidase inhibitory activity of pyrogallol

(2017) Sari Honda et al.   FREE RADICAL BIOLOGY AND MEDICINE

Diphlorethohydroxycarmalol from Ishige okamurae Suppresses Osteoclast Differentiation by Downregulating the NF-κB Signaling Pathway

(2017) Hye Ihn et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

OCLI-023, a Novel Pyrimidine Compound, Suppresses Osteoclastogenesis In Vitro and Alveolar Bone Resorption In Vivo

(2017) Hye Jung Ihn et al.   PLoS One

Bisphosphonate-associated adverse events

(2014) Peter Papapetrou   Hormones-International Journal of Endocrinology and Metabolism

Purpurogallin exerts anti-inflammatory effects in lipopolysaccharide-stimulated BV2 microglial cells through the inactivation of the NF-κB and MAPK signaling pathways

(2013) HYE YOUNG PARK et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday

(2012) Michael McClung et al.   AMERICAN JOURNAL OF MEDICINE

Negative regulation of osteoclast precursor differentiation by CD11b andβ2 integrin-B-cell lymphoma 6 signaling

(2012) Kyung-Hyun Park-Min et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The Blimp1–Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis

(2010) Yoshiteru Miyauchi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Blimp1-mediated repression of negative regulators is required for osteoclast differentiation

(2010) K. Nishikawa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Osteoporosis treatments and adverse events

(2009) Daniel H Solomon et al.   CURRENT OPINION IN RHEUMATOLOGY

Normal Bone Anatomy and Physiology

(2008) B. Clarke   Clinical Journal of the American Society of Nephrology

JNK/c-Jun Signaling Mediates an Anti-Apoptotic Effect of RANKL in Osteoclasts

(2008) Fumiyo Ikeda et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Pathogenesis of myeloma bone disease

(2008) G D Roodman   LEUKEMIA

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy

(2008) R. G. G. Russell et al.   OSTEOPOROSIS INTERNATIONAL